Back to search

University of Birmingham

Identification and evaluation of biomarkers for the detection of bladder cancer

Abstract

dc:description.abstract

Urinary Bladder Cancer (UBC) is the 5th most common cancer in the West (Cancer Research UK 2014). Continuous efforts have been made to develop non-invasive urine-based biomarkers with high sensitivity and specificity that would improve patients’ quality of life, costs and lower the number of cystoscopies (Bryan et al. 2010). This can then be utilized as part of a multi-biomarker panel to develop a urine test for UBC diagnosis as a single marker is unable to replace current diagnostic invasive tools (Brentnall et al. 2012). PMA increases secretion and shedding of proteins and has an effect on the cell phenotype. Despite Marimastat inhibits shedding of EpCAM, it does not have an effect on cell phenotype. Urinary MMP1 is not a useful neither prognostic nor diagnostic biomarker of UBC. Elevated MMP-1 levels are only apparent in high stages and grade.

Degree

thesis:*
Name dc:type.qualificationname
m_rs
Level dc:type.qualificationlevel
m_rs
Grantor dc:publisher.institution
University of Birmingham
Year dc:date.issued
2014

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Abbas, Hafsa

Subjects

dc:subject × 1

Rights

Language dc:language.dcterms_iso639_2
eng

Chain of custody

source
Harvested from
University of Birmingham
Base URL
etheses.bham.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Abbas, Hafsa. Identification and evaluation of biomarkers for the detection of bladder cancer. m_rs thesis, University of Birmingham, 2014.